AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 208 filers reported holding AMICUS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $4,000 | 0.0% | 300 | 0.0% | 0.00% | -50.0% |
Q1 2019 | $4,000 | +33.3% | 300 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $3,000 | -25.0% | 300 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $4,000 | -20.0% | 300 | 0.0% | 0.00% | -33.3% |
Q2 2018 | $5,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $5,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 9,029,843 | $89,576,043 | 10.38% |
Perceptive Advisors | 28,057,456 | $278,329,964 | 6.70% |
Redmile Group, LLC | 10,595,089 | $105,103,283 | 6.36% |
STEMPOINT CAPITAL LP | 1,495,047 | $14,830,866 | 4.36% |
CM Management, LLC | 450,000 | $4,464,000 | 4.10% |
Avoro Capital Advisors LLC | 27,400,000 | $271,808,000 | 3.62% |
GREAT POINT PARTNERS LLC | 1,495,500 | $14,835,360 | 2.84% |
Saturn V Capital Management LP | 713,536 | $7,078,277 | 2.68% |
AlphaCentric Advisors LLC | 202,500 | $2,008,800 | 1.48% |
Novo Holdings A/S | 2,500,000 | $24,800,000 | 1.44% |